LEI 213800XTW4IPFATDAT04
EUROPEAN MEDICINES AGENCY
Contract awards & public grants
Breakthrough Regulatory Innovation and Development throuGh sandbox Environments → THE EUROPEAN MEDICINES AGENCY
European Commission · NL · Grant · 2025-11-07
€197,595
Comprehensive methodological and operational approach to clinical trials in rare and ultra-rare diseases → THE EUROPEAN MEDICINES AGENCY
European Commission · NL · Grant · 2024-12-12
€554,459
European Partnership Animal health and Welfare → THE EUROPEAN MEDICINES AGENCY
European Commission · NL · Grant · 2024-02-28
—
Exploiting fundamental insights of m6A methylation on CD8 T cell differentiation and function to boost medicinal T cell products → THE EUROPEAN MEDICINES AGENCY
European Commission · NL · Grant · 2023-03-27
—
Establishing international standards in the analysis of patient reported outcomes and health-related quality of life data in cancer clinical trials → THE EUROPEAN MEDICINES AGENCY
European Commission · NL · Grant · 2020-11-09
€60,756
Prioritisation and Risk Evaluation of Medicines in the EnviRonment → THE EUROPEAN MEDICINES AGENCY
European Commission · NL · Grant · 2020-06-24
€47,000
Building an ecosystem for better monitoring and communicating of medication safety in pregnancy and breastfeeding: validated and regulatory endorsed w → THE EUROPEAN MEDICINES AGENCY
European Commission · NL · Grant · 2019-05-06
€33,158
Strengthening training of academia in regulatory sciences and supporting regulatory scientific advice (STARS) → THE EUROPEAN MEDICINES AGENCY
European Commission · NL · Grant · 2018-11-20
€7,500
Accelerated Development of Appropriate Patient Therapies: a Sustainable, Multi-stakeholder Approach from Research to Treatment-outcomes - Sofia ref.: → THE EUROPEAN MEDICINES AGENCY
European Commission · NL · Grant · 2015-09-02
—
Entity identity is matched from published recipient names and registry IDs to GLEIF legal-entity records; matches can be imperfect. Source records are public procurement and grant notices.